{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:02:21Z","timestamp":1793188941456,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Living with advanced renal cell carcinoma (RCC) can be challenging. Previous research suggests that patients are faced with variable complexities, although the main focus has been on physical problems. We aimed to generate empirical evidence to better understand patients\u2019 perceptions of adverse impact on wellbeing, to reveal priority concerns, and to explore moderators that could point to a greater risk for declining health status in this patient population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A prospective, international, and cross-sectional online survey was conducted, comprising a demographic\/clinical data form, the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) questionnaire, and bespoke closed- and open-ended questions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Data from 105 participants were analysed. The typical participant was male, on targeted therapy, and middle-aged (median 42\u00a0years), with a median of 54\u00a0months since diagnosis, and predominantly originated from the USA or UK. Being unable to work (46%), worrying that their condition would worsen (45%), concerns about psychological support for their partner or family (44%), and being burdened by urinary frequency (43%) were major problems for over 40% of this sample. Concerns about future response to treatment, running out of treatment options, cancer relapse, declining health, dying, and impact on family were also expressed. Older age was linked to higher wellbeing scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Relying on patient-reported outcomes, we were able to reveal the impact of advanced RCC and its management on several interrelated areas of patient wellbeing. These findings need to be validated in other contexts to ensure they are generalisable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09585-5","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:35:00Z","timestamp":1748918100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Wellbeing status and priority concerns of patients with advanced renal cell carcinoma: results of the EONS PROMs project international online survey"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-9989","authenticated-orcid":false,"given":"Grigorios","family":"Kotronoulas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-2106","authenticated-orcid":false,"given":"Celia Diez de los Rios","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-5673","authenticated-orcid":false,"given":"Amanda","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6855-6505","authenticated-orcid":false,"given":"Wendy H.","family":"Oldenmenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1847-0655","authenticated-orcid":false,"given":"Daniel","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"9585_CR1","unstructured":"Garfield K, LaGrange C (2023) Renal cell cancer. [Updated 2023 Jul 31]. In: StatPearls [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470336\/. Accessed 23 Sep 2023"},{"key":"9585_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/WJON1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC et al (2020) Epidemiology of renal cell carcinoma. World J Oncol 11:79\u201387. https:\/\/doi.org\/10.14740\/WJON1279","journal-title":"World J Oncol"},{"key":"9585_CR3","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.adcanc.2023.100094","volume":"7","author":"R Kanwal","year":"2023","unstructured":"Kanwal R (2023) Metastasis in renal cell carcinoma: biology and treatment. Adv Cancer Biol - Metastasis 7:100094. https:\/\/doi.org\/10.1016\/j.adcanc.2023.100094","journal-title":"Adv Cancer Biol - Metastasis"},{"key":"9585_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40487-018-0057-7","volume":"6","author":"B Storbjerg","year":"2018","unstructured":"Storbjerg B, Donskov F (2018) Living with advanced kidney cancer and treatment with cabozantinib: through the eyes of the patient and the physician. Oncol Ther 6:1\u20137. https:\/\/doi.org\/10.1007\/s40487-018-0057-7","journal-title":"Oncol Ther"},{"key":"9585_CR5","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2217\/fon-2020-1266","volume":"17","author":"J Hall","year":"2021","unstructured":"Hall J, Zanotti G, Kim R et al (2021) Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancer. Futur Oncol 17:2169\u20132182. https:\/\/doi.org\/10.2217\/fon-2020-1266","journal-title":"Futur Oncol"},{"key":"9585_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s11764-021-01113-8","volume":"16","author":"A O\u2019Dea","year":"2022","unstructured":"O\u2019Dea A, Gedye C, Jago B, Paterson C (2022) Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review. J Cancer Surviv 16:1279\u20131295. https:\/\/doi.org\/10.1007\/s11764-021-01113-8","journal-title":"J Cancer Surviv"},{"key":"9585_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.35680\/2372-0247.1053s","volume":"2","author":"R Harris","year":"2015","unstructured":"Harris R, Oake K, Hawkins RE et al (2015) Patient needs in advanced renal cell carcinoma: what are patients\u2019 priorities and how well are we meeting them? Patient Exp J 2:142\u2013152. https:\/\/doi.org\/10.35680\/2372-0247.1053s","journal-title":"Patient Exp J"},{"key":"9585_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32:1480\u20131501. https:\/\/doi.org\/10.1200\/JCO.2013.53.5948","journal-title":"J Clin Oncol"},{"key":"9585_CR9","unstructured":"Basch EM (2016) The rise of patient-reported outcomes in oncology. In: ASCO Dly. News. https:\/\/am.asco.org\/daily-news\/rise-patient-reported-outcomes-oncology. Accessed 7 Aug 2018"},{"key":"9585_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","volume":"33","author":"M Di Maio","year":"2022","unstructured":"Di Maio M, Basch E, Denis F et al (2022) The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol 33:878\u2013892. https:\/\/doi.org\/10.1016\/j.annonc.2022.04.007","journal-title":"Ann Oncol"},{"key":"9585_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s41687-022-00532-0","volume":"6","author":"S-H Hong","year":"2022","unstructured":"Hong S-H, Chung HS, Seo I-Y et al (2022) Patients\u2019 self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: a prospective, longitudinal, observational study. J Patient Reported Outcomes 6:125. https:\/\/doi.org\/10.1186\/s41687-022-00532-0","journal-title":"J Patient Reported Outcomes"},{"key":"9585_CR12","doi-asserted-by":"publisher","unstructured":"Diez de los Rios de la Serna C, Drury A, Oldenmenger WH, et al (2023) A delphi study of core patient-reported outcomes for advanced renal cell carcinoma and advanced hepatocellular carcinoma. Semin Oncol Nurs 39:151409. https:\/\/doi.org\/10.1016\/j.soncn.2023.151409","DOI":"10.1016\/j.soncn.2023.151409"},{"key":"9585_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.6004\/jadpro.2015.6.2.9","volume":"6","author":"J Ponto","year":"2015","unstructured":"Ponto J (2015) Understanding and evaluating survey research. J Adv Pract Oncol 6:168\u2013171. https:\/\/doi.org\/10.6004\/jadpro.2015.6.2.9","journal-title":"J Adv Pract Oncol"},{"key":"9585_CR14","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T et al (2021) A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med 36:3179\u20133187. https:\/\/doi.org\/10.1007\/s11606-021-06737-1","journal-title":"J Gen Intern Med"},{"key":"9585_CR15","unstructured":"European Association of Urology (2023) Renal cell carcinoma 4. Staging and classification systems. In: EAU. https:\/\/uroweb.org\/guidelines\/renal-cell-carcinoma\/chapter\/staging-and-classification-systems. Accessed 15 Dec 2023"},{"key":"9585_CR16","unstructured":"International Agency for Research on Cancer (2020) GLOBOCAN: estimated number of new cases in 2020, worldwide, both sexes, all ages. In: WHO. https:\/\/gco.iarc.fr\/today\/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&i. Accessed 31 Jan 2021"},{"key":"9585_CR17","unstructured":"Cancer.net (2020) Kidney cancer: statistics. In: ASCO. https:\/\/www.cancer.net\/cancer-types\/kidney-cancer\/statistics#:~:text=This year%2C an estimated 73%2C750,most common cancer for women. Accessed 4 Feb 2021"},{"key":"9585_CR18","unstructured":"Bristol-Myers Squibb (2016) Kidney cancer: a spotlight on the challenges. In: Kidney Cancer UK. https:\/\/www.kcuk.org.uk\/wp-content\/uploads\/2016\/05\/Final-Kidney-Cancer-Challenges-Report-certified.pdf. Accessed 4 Feb 2021"},{"key":"9585_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/B:QURE.0000015297.91158.01","volume":"13","author":"J Bacik","year":"2004","unstructured":"Bacik J, Mazumdar M, Murphy BA et al (2004) The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers. Qual life Res an Int J Qual life Asp Treat care Rehabil 13:137\u2013154. https:\/\/doi.org\/10.1023\/B:QURE.0000015297.91158.01","journal-title":"Qual life Res an Int J Qual life Asp Treat care Rehabil"},{"key":"9585_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11136-004-1694-x","volume":"14","author":"AG Paterson","year":"2005","unstructured":"Paterson AG, Trask PC, Wagner LI et al (2005) Validation of the FACT-BRM with interferon-alpha treated melanoma patients. Qual life Res an Int J Qual life Asp Treat care Rehabil 14:133\u2013139. https:\/\/doi.org\/10.1007\/s11136-004-1694-x","journal-title":"Qual life Res an Int J Qual life Asp Treat care Rehabil"},{"key":"9585_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.afjem.2017.08.001","volume":"7","author":"C Erlingsson","year":"2017","unstructured":"Erlingsson C, Brysiewicz P (2017) A hands-on guide to doing content analysis. African J Emerg Med 7:93\u201399. https:\/\/doi.org\/10.1016\/j.afjem.2017.08.001","journal-title":"African J Emerg Med"},{"key":"9585_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1037\/0021-9010.78.1.98","volume":"78","author":"JM Cortina","year":"1993","unstructured":"Cortina JM (1993) What is coefficient alpha? An examination of theory and applications. J Appl Psychol 78:98\u2013104. https:\/\/doi.org\/10.1037\/0021-9010.78.1.98","journal-title":"J Appl Psychol"},{"key":"9585_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13187-020-01941-9","volume":"36","author":"M Evans Webb","year":"2021","unstructured":"Evans Webb M, Murray E, Younger ZW et al (2021) The supportive care needs of cancer patients: a systematic review. J Cancer Educ 36:899\u2013908. https:\/\/doi.org\/10.1007\/s13187-020-01941-9","journal-title":"J Cancer Educ"},{"key":"9585_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.soncn.2016.08.001","volume":"32","author":"A Barsevick","year":"2016","unstructured":"Barsevick A (2016) Defining the symptom cluster: how far have we come? Semin Oncol Nurs 32:334\u2013350. https:\/\/doi.org\/10.1016\/j.soncn.2016.08.001","journal-title":"Semin Oncol Nurs"},{"key":"9585_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12904-023-01296-0","volume":"22","author":"D Gesell","year":"2023","unstructured":"Gesell D, Hodiamont F, Wikert J et al (2023) Symptom and problem clusters in German specialist palliative home care - a factor analysis of non-oncological and oncological patients\u2019 symptom burden. BMC Palliat Care 22:183. https:\/\/doi.org\/10.1186\/s12904-023-01296-0","journal-title":"BMC Palliat Care"},{"key":"9585_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpainsymman.2013.08.018","volume":"48","author":"S Stiel","year":"2014","unstructured":"Stiel S, Matthies DMK, Seu\u00df D et al (2014) Symptoms and problem clusters in cancer and non-cancer patients in specialized palliative care-is there a difference? J Pain Symptom Manage 48:26\u201335. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.08.018","journal-title":"J Pain Symptom Manage"},{"key":"9585_CR27","doi-asserted-by":"publisher","first-page":"103434","DOI":"10.1016\/j.ijnurstu.2019.103434","volume":"101","author":"A Drury","year":"2020","unstructured":"Drury A, Payne S, Brady AM (2020) Identifying associations between quality of life outcomes and healthcare-related variables among colorectal cancer survivors: a cross-sectional survey study. Int J Nurs Stud 101:103434. https:\/\/doi.org\/10.1016\/j.ijnurstu.2019.103434","journal-title":"Int J Nurs Stud"},{"key":"9585_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.pec.2017.03.019","volume":"100","author":"JH Hibbard","year":"2017","unstructured":"Hibbard JH, Mahoney E, Sonet E (2017) Does patient activation level affect the cancer patient journey? Patient Educ Couns 100:1276\u20131279. https:\/\/doi.org\/10.1016\/j.pec.2017.03.019","journal-title":"Patient Educ Couns"},{"key":"9585_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/NCC.0000000000000250","volume":"39","author":"M Verbrugghe","year":"2016","unstructured":"Verbrugghe M, Duprez V, Beeckman D et al (2016) Factors influencing adherence in cancer patients taking oral tyrosine kinase inhibitors: a qualitative study. Cancer Nurs 39:153\u2013162. https:\/\/doi.org\/10.1097\/NCC.0000000000000250","journal-title":"Cancer Nurs"},{"key":"9585_CR30","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00520-014-2223-2","volume":"22","author":"JJ Koldenhof","year":"2014","unstructured":"Koldenhof JJ, Witteveen PO, de Vos R et al (2014) Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions. Support care cancer Off J Multinatl Assoc Support Care Cancer 22:2371\u20132380. https:\/\/doi.org\/10.1007\/s00520-014-2223-2","journal-title":"Support care cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"9585_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00520-023-07934-w","volume":"31","author":"AM da Silva Lopes","year":"2023","unstructured":"da Silva Lopes AM, Colomer-Lahiguera S, Darnac C et al (2023) Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors. Support care cancer Off J Multinatl Assoc Support Care Cancer 31:484. https:\/\/doi.org\/10.1007\/s00520-023-07934-w","journal-title":"Support care cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"9585_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/cncr.33327","volume":"127","author":"JE Bower","year":"2021","unstructured":"Bower JE, Ganz PA, Irwin MR et al (2021) Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer. Cancer 127:1334\u20131344. https:\/\/doi.org\/10.1002\/cncr.33327","journal-title":"Cancer"},{"key":"9585_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2020.07.037","volume":"61","author":"M Al Maqbali","year":"2021","unstructured":"Al Maqbali M, Al Sinani M, Al Naamani Z et al (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage 61:167-189.e14. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.07.037","journal-title":"J Pain Symptom Manage"},{"key":"9585_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s41687-022-00509-z","volume":"6","author":"L Consolo","year":"2022","unstructured":"Consolo L, Castellini G, Cilluffo S et al (2022) Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review. J Patient Reported Outcomes 6:102. https:\/\/doi.org\/10.1186\/s41687-022-00509-z","journal-title":"J Patient Reported Outcomes"},{"key":"9585_CR35","doi-asserted-by":"publisher","first-page":"151145","DOI":"10.1016\/j.soncn.2021.151145","volume":"37","author":"KE P\u00e9rez-Alfonso","year":"2021","unstructured":"P\u00e9rez-Alfonso KE, S\u00e1nchez-Mart\u00ednez V (2021) Electronic patient-reported outcome measures evaluating cancer symptoms: a systematic review. Semin Oncol Nurs 37:151145. https:\/\/doi.org\/10.1016\/j.soncn.2021.151145","journal-title":"Semin Oncol Nurs"},{"key":"9585_CR36","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/pon.5054","volume":"28","author":"A Shrestha","year":"2019","unstructured":"Shrestha A, Martin C, Burton M et al (2019) Quality of life versus length of life considerations in cancer patients: a systematic literature review. Psychooncology 28:1367\u20131380. https:\/\/doi.org\/10.1002\/pon.5054","journal-title":"Psychooncology"},{"key":"9585_CR37","doi-asserted-by":"publisher","first-page":"e245866","DOI":"10.1001\/jamanetworkopen.2024.5866","volume":"7","author":"S Ozdemir","year":"2024","unstructured":"Ozdemir S, Chaudhry I, Malhotra C et al (2024) Goals of care among patients with advanced cancer and their family caregivers in the last years of life. JAMA Netw open 7:e245866. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.5866","journal-title":"JAMA Netw open"},{"key":"9585_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euros.2021.12.003","volume":"37","author":"R Giles","year":"2022","unstructured":"Giles R, Maskens D, Bick R et al (2022) Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: results from a global patient survey in 43 countries. Eur Urol open Sci 37:3\u20136. https:\/\/doi.org\/10.1016\/j.euros.2021.12.003","journal-title":"Eur Urol open Sci"},{"key":"9585_CR39","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1049732318816298","volume":"30","author":"M Arantzamendi","year":"2020","unstructured":"Arantzamendi M, Garc\u00eda-Rueda N, Carvajal A, Robinson CA (2020) People with advanced cancer: the process of living well with awareness of dying. Qual Health Res 30:1143\u20131155. https:\/\/doi.org\/10.1177\/1049732318816298","journal-title":"Qual Health Res"},{"key":"9585_CR40","doi-asserted-by":"publisher","first-page":"e1818","DOI":"10.1200\/OP.22.00185","volume":"18","author":"NCA van der Velden","year":"2022","unstructured":"van der Velden NCA, van Laarhoven HWM, Nieuwkerk PT et al (2022) Attitudes toward striving for quality and length of life among patients with advanced cancer and a poor prognosis. JCO Oncol Pract 18:e1818\u2013e1830. https:\/\/doi.org\/10.1200\/OP.22.00185","journal-title":"JCO Oncol Pract"},{"key":"9585_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/JMDH.S393457","volume":"16","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Zhu S, Wang Z et al (2023) Multidisciplinary team (MDT) discussion improves overall survival outcomes for metastatic renal cell carcinoma patients. J Multidiscip Healthc 16:503\u2013513. https:\/\/doi.org\/10.2147\/JMDH.S393457","journal-title":"J Multidiscip Healthc"},{"key":"9585_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34:557\u2013565. https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"key":"9585_CR43","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.3390\/cancers15153860","volume":"15","author":"F Scott\u00e9","year":"2023","unstructured":"Scott\u00e9 F, Taylor A, Davies A (2023) Supportive care: the \u201ckeystone\u201d of modern oncology practice. Cancers (Basel) 15:3860. https:\/\/doi.org\/10.3390\/cancers15153860","journal-title":"Cancers (Basel)"},{"key":"9585_CR44","doi-asserted-by":"publisher","unstructured":"Papachristou N, Kartsidis P, Anagnostopoulou A et al (2023) A smart digital health platform to enable monitoring of quality of life and frailty in older patients with cancer: a mixed-methods, feasibility study protocol. Semin Oncol Nurs 151437. https:\/\/doi.org\/10.1016\/j.soncn.2023.151437","DOI":"10.1016\/j.soncn.2023.151437"},{"key":"9585_CR45","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.3390\/cancers15194710","volume":"15","author":"PG Poudel","year":"2023","unstructured":"Poudel PG, Horan MR, Brinkman TM et al (2023) Interventions with social integration components addressing psychosocial outcomes of young- and middle-aged adult cancer individuals: a systematic review. Cancers (Basel) 15:4710. https:\/\/doi.org\/10.3390\/cancers15194710","journal-title":"Cancers (Basel)"},{"key":"9585_CR46","doi-asserted-by":"publisher","first-page":"e24722","DOI":"10.2196\/24722","volume":"23","author":"M Marthick","year":"2021","unstructured":"Marthick M, McGregor D, Alison J et al (2021) Supportive care interventions for people with cancer assisted by digital technology: systematic review. J Med Internet Res 23:e24722. https:\/\/doi.org\/10.2196\/24722","journal-title":"J Med Internet Res"},{"key":"9585_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12955-023-02189-9","volume":"21","author":"LB Nguyen","year":"2023","unstructured":"Nguyen LB, Vu LG, Le TT et al (2023) Impact of interventions on the quality of life of cancer patients: a systematic review and meta-analysis of longitudinal research. Health Qual Life Outcomes 21:112. https:\/\/doi.org\/10.1186\/s12955-023-02189-9","journal-title":"Health Qual Life Outcomes"},{"key":"9585_CR48","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1007\/s00520-022-07319-5","volume":"30","author":"A Cabanes","year":"2022","unstructured":"Cabanes A, Taylor C, Malburg C, Le PTD (2022) Supportive care interventions for cancer patients in low- and middle-income countries (LMICs): a scoping review. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 30:9483\u20139496. https:\/\/doi.org\/10.1007\/s00520-022-07319-5","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"9585_CR49","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1089\/jpm.2018.0256","volume":"22","author":"EA Meier","year":"2019","unstructured":"Meier EA, Naqvi JB, Xiao J, Montross LP (2019) Conversations regarding personhood: use of the patient dignity question in an outpatient psycho-oncology clinic. J Palliat Med 22:1574\u20131577. https:\/\/doi.org\/10.1089\/jpm.2018.0256","journal-title":"J Palliat Med"},{"key":"9585_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00520-024-08465-8","volume":"32","author":"NH Hart","year":"2024","unstructured":"Hart NH, Nekhlyudov L, Smith TJ et al (2024) Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations. Support Care Cancer 32:313. https:\/\/doi.org\/10.1007\/s00520-024-08465-8","journal-title":"Support Care Cancer"},{"key":"9585_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00520-023-08278-1","volume":"32","author":"N Colla\u00e7o","year":"2024","unstructured":"Colla\u00e7o N, Lippiett KA, Wright D et al (2024) Barriers and facilitators to integrated cancer care between primary and secondary care: a scoping review. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 32:120. https:\/\/doi.org\/10.1007\/s00520-023-08278-1","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"9585_CR52","doi-asserted-by":"publisher","first-page":"e13700","DOI":"10.1111\/ecc.13700","volume":"31","author":"M Jablotschkin","year":"2022","unstructured":"Jablotschkin M, Binkowski L, Markovits Hoopii R, Weis J (2022) Benefits and challenges of cancer peer support groups: a systematic review of qualitative studies. Eur J Cancer Care (Engl) 31:e13700. https:\/\/doi.org\/10.1111\/ecc.13700","journal-title":"Eur J Cancer Care (Engl)"},{"key":"9585_CR53","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/pon.5744","volume":"30","author":"VM White","year":"2021","unstructured":"White VM, Pejoski N, Vella E et al (2021) Improving access to cancer information and supportive care services: a systematic review of mechanisms applied to link people with cancer to psychosocial supportive care services. Psychooncology 30:1603\u20131625. https:\/\/doi.org\/10.1002\/pon.5744","journal-title":"Psychooncology"},{"key":"9585_CR54","doi-asserted-by":"publisher","first-page":"e43445","DOI":"10.7759\/cureus.43445","volume":"15","author":"S Kale","year":"2023","unstructured":"Kale S, Hirani S, Vardhan S et al (2023) Addressing cancer disparities through community engagement: lessons and best practices. Cureus 15:e43445. https:\/\/doi.org\/10.7759\/cureus.43445","journal-title":"Cureus"},{"key":"9585_CR55","doi-asserted-by":"publisher","unstructured":"Hughes RB, Robinson-Whelen S, Knudson C (2022) Cancer disparities experienced by people with disabilities. Int J Environ Res Public Health 19. https:\/\/doi.org\/10.3390\/ijerph19159187","DOI":"10.3390\/ijerph19159187"},{"key":"9585_CR56","doi-asserted-by":"publisher","unstructured":"Alessy SA, Alhajji M, Rawlinson J et al (2022) Factors influencing cancer patients&#x2019; experiences of care in the USA, United Kingdom, and Canada: a systematic review. eClinicalMedicine 47. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101405","DOI":"10.1016\/j.eclinm.2022.101405"},{"key":"9585_CR57","unstructured":"American Cancer Society Cancer Action Network (2024) Factors influencing cancer disparities. In: ACS CAN Public Policy Resour. https:\/\/www.fightcancer.org\/policy-resources\/factors-influencing-cancer-disparities. Accessed 14 May 2024"},{"key":"9585_CR58","unstructured":"Walsh L (2024) Cancer isn\u2019t fair \u2013 but care should be: listening to people\u2019s lived experiences is helping to improve the awareness and uptake of cancer care. In: Univ. Cambridge. https:\/\/www.cam.ac.uk\/stories\/close-the-cancer-care-gap. Accessed 14 May 2024"},{"key":"9585_CR59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/15384047.2019.1632132","volume":"20","author":"L Collado","year":"2019","unstructured":"Collado L, Brownell I (2019) The crippling financial toxicity of cancer in the United States. Cancer Biol Ther 20:1301\u20131303","journal-title":"Cancer Biol Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09585-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:03:43Z","timestamp":1749492223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9585"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09585-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}